SRSarah Elizabeth Ross

Sarah Elizabeth Ross

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sarah Elizabeth Ross has a total of 249 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Substance P regulates Tacr1 neurons, which control nitric oxide–mediated neurovascular coupling in the mouse cortex

    by Fernanda Juarez Anaya, Jiwon Kim, Sarah E. Ross, Alberto L. Vazquez

    Neuronal activity–driven increases in cerebral blood flow (CBF), known as neurovascular coupling (NVC), are crucial for sustaining the metabolic demands of the brain. Our group has found that Tacr1 neurons, a subset of somatostatin neurons expressing the substance P (SP) receptor and neuronal nitric oxide synthase (nNOS), exert a disproportionately large regulation of CBF. Here, we use two-photon imaging to show that Tacr1 neurons regulate CBF through nitric oxide (NO) release and SP-receptor signaling . We identify astrocytic calcium (Ca 2+ ) transients as a secondary response to vasodilation. To identify potential sources of SP in somatosensory cortex, viral mapping revealed Tac1 -positive neurons locally, predominantly among parvalbumin (PV) neurons, as well as Tac1 -positive long-range projections from perirhinal cortex. Functional analyses indicate that PV neurons regulate CBF through a Tacr1 neuron dependent pathway. These findings suggest a sequential mechanism whereby Tacr1 neurons respond to SP to release NO, inducing vasodilation and driving astrocytic Ca 2+ signaling.


  • Tegmental kappa-opioid receptor neurons modulate opioid withdrawal via the periaqueductal gray

    by Ruby A Holland, Kelly M Smith, Isabel B Bleimeister, Jeffrey J Okoro, Samantha A Sherman, Ava V Zoltanski, Michael C Chiang, BaDoi N Phan, Bryan M Hooks, Andreas R Pfenning, et al.

    Opioid withdrawal is a common and distressing manifestation of opioid dependence which, if left untreated, frequently results in relapse, accidental overdose, and suicide. While much is known about the role of mesolimbic and mesocortical dopaminergic neurons in mu opioid receptor-mediated reward, much less is understood about the impact of chronic opioid use on parallel aversive pathways mediated by the kappa opioid receptor and its endogenous ligand dynorphin. In the present study, we interrogate kappa opioid receptor-expressing ventral tegmental area neurons and their dynorphinergic inputs in vitro and in vivo, to elucidate the circuit mechanisms by which chronic opioids promote withdrawal behaviors in mice. Through a combination of genetic, molecular, and custom machine learning analytical approaches, we uncovered the effects of chronic morphine on kappa opioid receptor mRNA expression in the ventral tegmental area as well as dynorphin mRNA expression in several retrogradely traced dynorphinergic input regions. We find that chronic morphine exposure diminishes opioid-induced c-Fos expression selectively in midbrain kappa opioid receptor-expressing neurons. In addition, chemogenetic activation of kappa opioid receptor-expressing ventral tegmental area neurons was sufficient to attenuate diverse opioid withdrawal-associated behaviors, negative affect, and gastrointestinal distress in mice. Finally, we uncovered a glutamatergic subpopulation of kappa opioid receptor-expressing ventral tegmental area neurons projecting to the ventrolateral periaqueductal gray which, when activated, selectively relieved opioid withdrawal-associated gastrointestinal distress. These discoveries highlight a critical role for midbrain kappa opioid receptor-expressing neurons and the downstream ventrolateral periaqueductal gray in opioid withdrawal-associated disruption of hedonic homeostasis and gastrointestinal regulation.

  • Top Cited Papers

    Scratching promotes allergic inflammation and host defense via neurogenic mast cell activation

    by Andrew W. Liu, Youran R. Zhang, Chien-Sin Chen, Tara N. Edwards, Sumeyye Ozyaman, Torben Ramcke, Lindsay M. McKendrick, Eric S. Weiss, Jacob E. Gillis, Colin R. Laughlin, et al.

    Itch is a dominant symptom in dermatitis, and scratching promotes cutaneous inflammation, thereby worsening disease. However, the mechanisms through which scratching exacerbates inflammation and whether scratching provides benefit to the host are largely unknown. We found that scratching was required for skin inflammation in mouse models dependent on FcεRI-mediated mast cell activation. Scratching-induced inflammation required pain-sensing nociceptors, the neuropeptide substance P, and the mast cell receptor MrgprB2. Scratching also increased cutaneous inflammation and augmented host defense to superficial Staphylococcus aureus infection. Thus, through the activation of nociceptor-driven neuroinflammation, scratching both exacerbated allergic skin disease and provided protection from S. aureus , reconciling the seemingly paradoxical role of scratching as a pathological process and evolutionary adaptation.


  • Open Access

    Kappa opioids inhibit spinal output neurons to suppress itch

    by Tayler D. Sheahan, Charles A. Warwick, Abby Y. Cui, David A. A. Baranger, Vijay J. Perry, Kelly M. Smith, Allison P. Manalo, Eileen K. Nguyen, H. Richard Koerber, Sarah E. Ross

    Itch is a protective sensation that drives scratching. Although specific cell types have been proposed to underlie itch, the neural basis for itch remains unclear. Here, we used two-photon Ca 2+ imaging of the dorsal horn to visualize neuronal populations that are activated by itch-inducing agents. We identify a convergent population of spinal interneurons recruited by diverse itch-causing stimuli that represents a subset of neurons that express the gastrin-releasing peptide receptor (GRPR). Moreover, we find that itch is conveyed to the brain via GRPR-expressing spinal output neurons that target the lateral parabrachial nuclei. We then show that the kappa opioid receptor agonist nalfurafine relieves itch by selectively inhibiting GRPR spinoparabrachial neurons. These experiments provide a population-level view of the spinal neurons that respond to pruritic stimuli, pinpoint the output neurons that convey itch to the brain, and identify the cellular target of kappa opioid receptor agonists for the inhibition of itch.


  • Open Access

    Long-range inhibitory neurons mediate cortical neurovascular coupling

    by Catherine F. Ruff, Fernanda Juarez Anaya, Samuel J. Dienel, Adiya Rakymzhan, Alain Altamirano-Espinoza, Jonathan J. Couey, Mitsuhiro Fukuda, Alan M. Watson, Aihua Su, Kenneth N. Fish, et al.


  • Open Access

    The functional and anatomical characterization of three spinal output pathways of the anterolateral tract

    by Haichao Chen, Isabel H. Bleimeister, Eileen K. Nguyen, Jie Li, Abby Yilin Cui, Harrison J. Stratton, Kelly M. Smith, Mark L. Baccei, Sarah E. Ross


  • Open Access

    Molecular identification of wide-field amacrine cells in mouse retina that encode stimulus orientation

    by Silvia J. Park, Wanyu Lei, John Pisano, Andrea Orpia, Jacqueline Minehart, Joseph Pottackal, Christin Hanke-Gogokhia, Thomas E. Zapadka, Cheryl Clarkson-Paredes, Anastas Popratiloff, et al.

    Summary Visual information processing is sculpted by a diverse group of inhibitory interneurons in the retina called amacrine cells. Yet, for most of the >60 amacrine cell types, molecular identities and specialized functional attributes remain elusive. Here, we developed an intersectional genetic strategy to target a group of wide-field amacrine cells (WACs) in mouse retina that co-express the transcription factor Bhlhe22 and the Kappa Opioid Receptor (KOR; B/K WACs). B/K WACs feature straight, unbranched dendrites spanning over 0.5 mm (∼15° visual angle) and produce non-spiking responses to either light increments or decrements. Two-photon dendritic population imaging reveals Ca2+ signals tuned to the physical orientations of B/K WAC dendrites, signifying a robust structure-function alignment. B/K WACs establish divergent connections with multiple retinal neurons, including unexpected connections with non-orientation-tuned ganglion cells and bipolar cells. Our work sets the stage for future comprehensive investigations of the most enigmatic group of retinal neurons: WACs.


  • Open Access

    Molecular identification of wide-field amacrine cells in mouse retina that encode stimulus orientation

    by Silvia J. Park, Wanyu Lei, John Pisano, Andrea Orpia, Jacqueline Minehart, Joseph Pottackal, Christin Hanke-Gogokhia, Thomas E. Zapadka, Cheryl Clarkson-Paredes, Anastas Popratiloff, et al.

    SUMMARY: Visual information processing is sculpted by a diverse group of inhibitory interneurons in the retina called amacrine cells. Yet, for most of the >60 amacrine cell types, molecular identities and specialized functional attributes remain elusive. Here, we developed an intersectional genetic strategy to target a group of wide-field amacrine cells (WACs) in mouse retina that co-express the transcription factor Bhlhe22 and the Kappa Opioid Receptor (KOR; B/K WACs). B/K WACs feature straight, unbranched dendrites spanning over 0.5 mm (∼15° visual angle) and produce non-spiking responses to either light increments or decrements. Two-photon dendritic population imaging reveals Ca 2+ signals tuned to the physical orientations of B/K WAC dendrites, signifying a robust structure-function alignment. B/K WACs establish divergent connections with multiple retinal neurons, including unexpected connections with non-orientation-tuned ganglion cells and bipolar cells. Our work sets the stage for future comprehensive investigations of the most enigmatic group of retinal neurons: WACs.


  • Open Access

    Alleviation of neuropathic pain with neuropeptide Y requires spinal Npy1r interneurons that coexpress Grp

    by Tyler S. Nelson, Heather N. Allen, Paramita Basu, Pranav Prasoon, Eileen Nguyen, Cynthia M. Arokiaraj, Diogo F.S. Santos, Rebecca P. Seal, Sarah E. Ross, Andrew J. Todd, et al.

    Neuropeptide Y targets the Y1 receptor (Y1) in the spinal dorsal horn (DH) to produce endogenous and exogenous analgesia. DH interneurons that express Y1 (Y1-INs; encoded by Npy1r ) are necessary and sufficient for neuropathic hypersensitivity after peripheral nerve injury. However, as Y1-INs are heterogenous in composition in terms of morphology, neurophysiological characteristics, and gene expression, we hypothesized that a more precisely defined subpopulation mediates neuropathic hypersensitivity. Using fluorescence in situ hybridization, we found that Y1-INs segregate into 3 largely nonoverlapping subpopulations defined by the coexpression of Npy1r with gastrin-releasing peptide ( Grp / Npy1r ), neuropeptide FF ( Npff / Npy1r ), and cholecystokinin ( Cck / Npy1r ) in the superficial DH of mice, nonhuman primates, and humans. Next, we analyzed the functional significance of Grp / Npy1r , Npff / Npy1r , and Cck / Npy1r INs to neuropathic pain using a mouse model of peripheral nerve injury. We found that chemogenetic inhibition of Npff / Npy1r -INs did not change the behavioral signs of neuropathic pain. Further, inhibition of Y1-INs with an intrathecal Y1 agonist, [Leu 31 , Pro 34 ]-NPY, reduced neuropathic hypersensitivity in mice with conditional deletion of Npy1r from CCK-INs and NPFF-INs but not from GRP-INs. We conclude that Grp / Npy1r -INs are conserved in higher order mammalian species and represent a promising and precise pharmacotherapeutic target for the treatment of neuropathic pain.